Reference health
The Impact of Type 2 Diabetes in Parkinson's Disease
40/40 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
10 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 40 checked references that resolve
resolves10.1002/mds.28551
Type 2 Diabetes as a Determinant of Parkinson's Disease Risk and Progression
resolves10.1016/j.molmed.2013.01.002
Shared dysregulated pathways lead to Parkinson's disease and diabetes
resolves10.1371/journal.pone.0083940
Integrative Network Analysis Unveils Convergent Molecular Pathways in Parkinson's Disease and Diabetes
resolves10.1002/acn3.51343
Effect of diabetes control status on the progression of Parkinson’s disease: A prospective study
resolves10.1002/mds.27526
Earlier onset of motor complications in Parkinson's patients with comorbid diabetes mellitus
resolves10.1016/j.parkreldis.2013.01.016
Diabetes is associated with postural instability and gait difficulty in Parkinson disease
resolves10.1212/01.WNL.0000138432.16676.4B
Diabetes mellitus and progression of rigidity and gait disturbance in older persons
resolves10.1016/j.parkreldis.2014.10.008
Diabetes mellitus is independently associated with more severe cognitive impairment in Parkinson disease
resolves10.1002/mds.27492
Baseline predictors for progression 4 years after Parkinson's disease diagnosis in the De Novo Parkinson Cohort (DeNoPa)
resolves10.1016/j.parkreldis.2017.05.025
Clinical milestones in Parkinson's disease: A 7-year population-based incident cohort study
resolves10.1093/brain/awx056
Glycation potentiates α-synuclein-associated neurodegeneration in synucleinopathies
resolves10.1016/j.pneurobio.2016.10.001
Insulin resistance and Parkinson’s disease: A new target for disease modification?
resolves10.1002/pmrj.12337
Physical Therapy for Freezing of Gait and Gait Impairments in Parkinson Disease: A Systematic Review
resolves10.1002/mds.26698
Vascular disease and vascular risk factors in relation to motor features and cognition in early Parkinson's disease
resolves10.2337/dc12-0814
Macro- and Microstructural Magnetic Resonance Imaging Indices Associated With Diabetes Among Community-Dwelling Older Adults
resolves10.2337/dc12-0348
Subjective Sleep Complaints Are Associated With Insulin Resistance in Individuals Without Diabetes
resolves10.1016/j.pcd.2015.06.003
Investigating incretin-based therapies as a novel treatment for depression in type 2 diabetes: Findings from the South London Diabetes (SOUL-D) Study
resolves10.1523/JNEUROSCI.0925-05.2005
Involvement of the Dorsal Striatum in Cue-Controlled Cocaine Seeking
resolves10.1093/ijnp/pyv014
Reduced Insulin Sensitivity Is Related to Less Endogenous Dopamine at D2/3 Receptors in the Ventral Striatum of Healthy Nonobese Humans
resolves10.1073/pnas.0807991106
Antidiabetic drug metformin (Glucophage
<sup>R</sup>
) increases biogenesis of Alzheimer's amyloid peptides via up-regulating
<i>BACE1</i>
transcription
resolves10.1093/brain/awab015
Beneficial effects of dipeptidyl peptidase-4 inhibitors in diabetic Parkinson’s disease
resolves10.1212/WNL.0000000000006737
Age and time course of long-term motor and nonmotor complications in Parkinson disease
resolves10.1002/mds.24893
Diagnostic criteria for mild cognitive impairment in Parkinson's disease: <i>Movement</i> Disorder Society Task Force guidelines
resolves10.1212/WNL.0b013e3181c34b47
Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease
resolves10.1016/j.prdoa.2019.08.006
Prediction of cognitive progression in Parkinson's disease using three cognitive screening measures
resolves10.2190/BF8G-5J8L-YTRF-6404
Let's Ask Them: A National Survey of Definitions of Quality of Life and Its Enhancement among People Aged 65 and Over
resolves10.1136/jnnp.2011.240366
The natural history of treated Parkinson's disease in an incident, community based cohort
resolves10.1016/S1353-8020(01)00009-8
Reliability of measurements of patient health status: a comparison of physician, patient, and caregiver ratings
resolves10.1002/mds.22571
Validation of the questionnaire for impulsive‐compulsive disorders in Parkinson's disease
resolves10.1093/ije/dyaa213
Use of directed acyclic graphs (DAGs) to identify confounders in applied health research: review and recommendations
The 10 references without a DOI — listed, not checked
no DOI — not checkedGlobal, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study
no DOI — not checkedref22
no DOI — not checkedref31
no DOI — not checkedref32
no DOI — not checkedref33
no DOI — not checkedref34
no DOI — not checkedref35
no DOI — not checkedref36
no DOI — not checkedref37
no DOI — not checkedRobust causal inference using directed acyclic graphs: the R package "dagitty"
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.2139/ssrn.3928496"><img src="https://citestamp.com/citestamped/10.2139/ssrn.3928496/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.2139/ssrn.3928496)